Biofarma
Biofarma, officially known as Biofarma Group, is a prominent player in the pharmaceutical and biotechnology industry, headquartered in Italy. Established in 1978, the company has made significant strides in the development of innovative healthcare solutions, particularly in the fields of biopharmaceuticals and medical devices. With a strong operational presence across Europe and beyond, Biofarma is renowned for its commitment to quality and excellence. The company offers a diverse range of products and services, including contract manufacturing and research and development, which are distinguished by their adherence to stringent regulatory standards and a focus on patient-centric solutions. Recognised for its market leadership, Biofarma has achieved numerous milestones, solidifying its reputation as a trusted partner in the healthcare sector. Its dedication to innovation and sustainability continues to drive its success in an ever-evolving industry landscape.
DitchCarbon Score
How does Biofarma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biofarma's score of 20 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Biofarma's reported carbon emissions
In 2022, Biofarma reported total carbon emissions of approximately 14,014,000 kg CO2e, comprising 5,242,000 kg CO2e from Scope 1 and 6,862,000 kg CO2e from Scope 2 emissions. The company also recorded 8,000,000 kg CO2e in Scope 3 emissions from purchased goods and services in previous years. Over the years, Biofarma has demonstrated a commitment to reducing its carbon footprint. From 2019 to 2022, the company has made notable reductions in its Scope 1 emissions, decreasing from 51,060,000 kg CO2e in 2019 to 5,242,000 kg CO2e in 2022. This represents a significant achievement in their emissions management strategy. Despite these reductions, there are currently no specific reduction targets or climate pledges disclosed by Biofarma. The company continues to focus on improving its sustainability practices within the industry context, aiming to enhance its overall environmental performance.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 51,060,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 7,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 10,000,000 | 0,000,000 | 0,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biofarma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
